Macitentan Phase 1 study in Japanese healthy male subjects (clinical pharmacokinetics study)
Prospectiove, single-arm, Open-label, multi-center study to assess the efficacy, safety, and tolerability of ACT-385781A in Japanese children with pulmonary arterial hypertension.
Open-label, long-term, efficacy, safety, and tolerability extension study using ACT-385781A in the treatment of Japanese children with pulmonary arterial hypertension who completed the AC-066A308 study.
100 项与 Actelion Pharmaceuticals Japan Ltd. 相关的临床结果
0 项与 Actelion Pharmaceuticals Japan Ltd. 相关的专利(医药)
100 项与 Actelion Pharmaceuticals Japan Ltd. 相关的药物交易
100 项与 Actelion Pharmaceuticals Japan Ltd. 相关的转化医学